Group 1 - The core viewpoint of the article highlights that Yidu Technology (02158) has been actively repurchasing its shares for three consecutive days, signaling positive market sentiment [1] - The company repurchased 280,000 shares at a price of HKD 5.18 per share on December 5, with a total repurchase amount of HKD 1.4 million, bringing the total shares repurchased to approximately 853,000 and the cumulative repurchase amount exceeding HKD 4.3 million [1] - Yidu Technology reported a healthy revenue growth for the fiscal year 2026, achieving total revenue of RMB 358 million, which represents a year-on-year increase of 8.7% [1] Group 2 - The adjusted EBITDA for existing business reached approximately RMB 54 million, doubling compared to the same period last year, indicating significant improvement in profitability and operational efficiency [1] - The company has nearly reached breakeven on its financial statements, achieving this key financial milestone about a year earlier than previously anticipated by management [1] - A new collaboration has been initiated between Yidu Technology and Tsinghua Changgung Hospital to establish a digital technology research and development platform, marking a new phase in their partnership in the field of medical artificial intelligence [1]
医渡科技连续3日回购 累计斥资超430万港元